OSLI Retina

June 2020

Issue link: http://osliretina.healio.com/i/1260326

Contents of this Issue

Navigation

Page 48 of 63

June 2020 · Vol. 51, No. 6 355 years old. She had type 2 diabetes and was a non- smoker. Her medications included aspirin, metfor- min, lisinopril, hydrochlorothiazide, pravastatin, alprazolam, and vitamin D. Her initial visual acu- ity (VA) was 20/70 in the right eye with correction –2.75+0.25×160 and 20/20 in the left eye with cor- rection –1.75+1.00×027. Her posterior pole exam re- vealed bilateral pigmentary changes and numerous yellow flecks in the macula extending beyond the vascular arcades (Figures 1A and 1B). The fluoresce- in angiography (FA) showed hyperfluorescent flecks bilaterally, and there was unilateral leakage from choroidal neovascularization (CNV) in the right eye (Figures 2A and 2B). The initial treatment in the right eye was full-fluence photodynamic therapy (PDT) with intravitreal triamcinolone injection. Seven years later in 2012, she complained of metamorphopsia in the left eye. Her VA was 20/20 Figure 1. Right (A) and left (B) color fundus images of Patient A showing multiple yellow flecks in the macula extending beyond the vas- cular arcades in 2005. Right eye exhibits grey lesion nasal of the fovea. Figure 2. Right (A) and left (B) fluorescein angiography of Patient A demonstrating bilateral hyperfluorescent flecks and leakage from a choroidal neovascularization in the right eye in 2005 (A). (B) Window defect in the left eye.

Articles in this issue

Archives of this issue

view archives of OSLI Retina - June 2020